Kettering Health Network is no longer providing Ruxolitinib (RUX) to COVID-19 patients through the expanded access program. We are still enrolling COVID-19 patients on ventilators into the randomized RUX-DEVENT clinical trial.
For more details, you can contact the COVID Research Team through MatchMD. A physician quick glance sheet is available at:
Intranet Resources Pharmacies COVID 19 Drug Information